Dr. Kanstantsin Siniuk, postdoctoral researcher in the project group of Dr. Helmut Pospiech at the Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) Jena, has secured a 96,000 euro grant from the BMBF's GO-Bio initial program for his pioneering project on mitochondrial and neurodegenerative disease treatments.
Genomic Vision Announces Early Access Program for a New Detection Suite Based on Innovative Artificial Intelligence Technology
Genomic Vision
(the Company FR0011799907 GV), a biotechnology company that develops tools and services dedicated to the analysis and control of changes in the genome, today announced that it has initiated an early access program for FiberSmart, a new suite to automate the detection and quantification of fluorescent signals on combed DNA.
Through innovations in imaging, machine learning and Artificial Intelligence (AI), FiberSmart significantly enhances the automated signal detection, segmentation, and classification with 90% detection sensitivity per coverslip in the Replication Combing Assay (RCA) and 97% sensitivity for Facioscapulohumeral muscular dystrophy (FSHD) assay.